HEALTH
||
ASSESSMEN
||
T HESI RN|| ||
Q&A
, ADVANCED HEALTH ASSESSMENT HESI RN
|| || || ||
QUESTIONS AND ANSWERS
|| || ||
1. An ||antacid ||(Maalox) ||is ||prescribed ||for ||a ||client ||with ||peptic ||ulcer ||disease. |The ||nurse |knows
||that ||the ||purpose ||of ||this ||medication ||is ||to
A. Decrease ||production ||of ||gastric ||secretions.
B. Produce ||an ||adherent ||barrier ||over ||the ||ulcer.
C. Correct ||Maintain ||a ||gastric ||pH ||of ||3.5 ||or ||above.
D. Decrease ||gastric ||motor |activity.
2. In ||evaluating |the ||effects ||of |lactulose ||(Cephulac), ||which ||outcome ||would ||indicate ||that ||the
||drug ||is ||performing ||as ||intended?
A. An ||increase ||in ||urine ||output.
B. Correct. |Two ||or |three ||soft ||stools ||per ||day.
C. Watery, ||diarrhea ||stools
D. Increased ||serum ||bilirubin.
3. The ||healthcare ||provider ||prescribes ||digitalis ||(Digoxin) ||for ||a ||client ||diagnosed ||with ||congestive
||heart ||failure. ||Which ||intervention ||should ||the ||nurse ||implement ||prior ||to ||administering ||the
||digoxin? ||The ||healthcare ||provider ||prescribes ||digitalis ||(Digoxin) ||for ||a ||client ||diagnosed ||with
||congestive ||heart ||failure. ||Which ||intervention ||should ||the ||nurse ||implement ||prior ||to
||administering ||the ||digoxin?
a. Observe ||respiratory |rate ||and ||depth.
b. Correct |Assess ||the ||serum ||potassium ||level.
c. Obtain ||the ||client's ||blood ||pressure.
d. Monitor ||the ||serum ||glucose ||level.
4. Following ||the ||administration ||of ||sublingual ||nitroglycerin ||to ||a ||client ||experiencing ||an ||acute
||anginal ||attack, ||which ||assessment ||finding ||indicates ||to ||the ||nurse ||that ||the ||desired ||effect
||has ||been ||achieved?
A. Correct ||Client ||states ||chest ||pain ||is ||relieved.
B. Client's ||pulse ||decreases ||from ||120 ||to ||90.
C. Client's ||systolic ||blood ||pressure ||decreases ||from ||180 ||to ||90.
D. Client's ||SaO2 ||level ||increases ||from ||92% ||to ||96%.
5. A ||client ||with ||congestive |heart ||failure ||(CHF) |is ||being ||discharged ||with ||a ||new ||prescription ||for
||the ||angiotensin-converting ||enzyme ||(ACE) ||inhibitor ||captopril ||(Capoten). ||The ||nurse's
||discharge ||instruction ||should ||include ||reporting ||which ||problem ||to ||the ||healthcare ||provider?